Genetic Alterations in Cyclin-Dependent Kinases Highlight Potential Cancer Treatment Approach

Aug

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Aug

Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Aug

Featured Webinar

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are treated with tyrosine kinase inhibitors (TKIs), which often leads to prolonged overall survival. However, treatment resistance will almost inevitably occur, and the disease remains incurable.

Aug

Featured Webinar

CRISPR/Cas9 Screens to Investigate Mechanisms of Cancer Drug Resistance

Over 70 percent of breast cancers are estrogen receptor positive and are treated with endocrine therapy.

Menu

Genetic Alterations in Cyclin-Dependent Kinases Highlight Potential Cancer Treatment Approach

To read the full story....

Breaking News

Guardant Health CDx Wins FDA Approval for First Liquid Biopsy NGS Tumor Profiling Assay

Researchers Use CRISPR-Cas13 Platform to Interrogate Gene Function in Animal Embryos

New Products Posted to GenomeWeb: Illumina, Adaptive Biotechnologies, Personalis, More

In Brief This Week: ArcherDx, NanoString Technologies, the Cleveland Clinic, and More

Bruker, Utrecht University Partnering on Mass Spec Methods

People in the News: New Appointments at Pacific Biosciences, Lexogen, Tangen Biosciences, More

Recent Headlines from
Precision Oncology News

Real-World, Umbrella Studies Highlight Challenges of Evaluating Precision Oncology in NSCLC

UCSF Glioblastoma Projects Using Molecular Data to Inform Subtypes, Match Patients to Treatments

Puma's Nerlynx Offers Targeted Treatment Opportunity for HER2-Mutant Cervical Cancer in Basket Trial

Merus, Elevation Oncology Advance Drug Candidates Targeting NRG1 Fusion-Positive Cancers

MMRF Programs Aim to Boost Precision Med Knowledge, Access in Multiple Myeloma

Featured White Papers

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

Utility of Novel RNA-Based Tools in Oncology Drug Development

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

CRISPR/Cas9 Screens to Investigate Mechanisms of Cancer Drug Resistance

What's Popular?

Guardant Health CDx Wins FDA Approval for First Liquid Biopsy NGS Tumor Profiling Assay

Guardant Health Colorectal Cancer Early-Detection Test Progresses Despite Pandemic Challenges

Natera Files Additional Patent Infringement Lawsuit Against ArcherDx

Rakuten Medical Sues Illumina Over Trademark Dispute

Computational Tool Analyzes Noncoding Mutations to Classify Cancer Subtypes

Sponsorships